GENETIC ANALYSIS NK -60 (8V8) — Tangible Net Worth Ratio
GENETIC ANALYSIS NK -60 (8V8) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets (€0.00) from net assets (€27.08 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See shareholders equity of GENETIC ANALYSIS NK -60 for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
GENETIC ANALYSIS NK -60 Tangible Net Worth Ratio (2021–2025)
This chart shows how GENETIC ANALYSIS NK -60's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of €27.08 Million with intangible assets of €0.00 EUR. Also explore 8V8 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for GENETIC ANALYSIS NK -60 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for GENETIC ANALYSIS NK -60 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see GENETIC ANALYSIS NK -60 market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | €27.08 Million | €0.00 | €52.45 Million | ▲ +69.8 pp |
| 2024 | 30.2% | €22.49 Million | €15.71 Million | €42.38 Million | ▼ -14.1 pp |
| 2023 | 44.3% | €32.00 Million | €17.83 Million | €53.49 Million | ▼ -8.5 pp |
| 2022 | 52.8% | €44.14 Million | €20.85 Million | €64.42 Million | ▼ -13.5 pp |
| 2021 | 66.3% | €72.09 Million | €24.31 Million | €83.49 Million | — |